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Abstract: Endoplasmic reticulum (ER) homeostasis is critical in maintaining metabolic regulation.
Once it is disrupted due to accumulated unfolded proteins, ER homeostasis is restored via
activation of the unfolded protein response (UPR); hence, the UPR affects diverse physiological
processes. However, how ER stress influences adipocyte functions is not well known. In this study,
we investigated the effect of ER stress in thermogenic capacity of mice beige adipocytes. Here,
we show that the expression of uncoupling protein 1 (Ucp1) involved in thermoregulation is severely
suppressed under ER stress conditions (afflicted by tunicamycin) in inguinal white adipose tissue
(IWAT) both in vitro and in vivo. Further investigation showed that extracellular signal-regulated
kinase (ERK) and c-Jun N-terminal kinase (JNK) were both activated after ER stress stimulation and
regulated the mRNA levels of Ucp1 and peroxisome proliferator-activated receptor γ (Pparγ), which
is known as a Ucp1 transcriptional activator, in vitro and ex vivo. We also found that Pparγ protein
was significantly degraded, reducing its recruitment to the Ucp1 enhancer, thereby downregulating
Ucp1 expression. Additionally, only JNK inhibition, but not ERK, rescued the Pparγ protein. These
findings provide novel insights into the regulatory effect of ER stress on Ucp1 expression via Pparγ
suppression in beige adipocytes.
Keywords: beige adipocytes; endoplasmic reticulum stress; peroxisome proliferator-activated
receptor γ; uncoupling protein 1
1. Introduction
Adipose tissue has been broadly characterized as white and brown adipocytes through their
distinct characteristics in lipid metabolism. White adipose tissue (WAT) functions as energy
storage, while brown adipose tissue (BAT) dissipates energy as heat supported by its high oxidative
capacity [1–3]. Recent findings show inducible brown-like white adipocytes, known as beige
adipocytes. Beige adipocytes are developed within WAT in response to β-adrenergic receptor
(β-AR) stimulation, termed as browning of WAT, and exhibit similar characteristic as BAT [2,4].
The transcription of uncoupling protein 1 (Ucp1) is tightly regulated during browning, thus it is
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often used as a browning marker of adipose tissue [1,5]. Interestingly, in addition to browning, beige
adipocytes also show unique plasticity to undergo whitening (reversal of browning) [6–8].
The endoplasmic reticulum (ER) is a critical organelle in sensing and handling cellular nutrient
required for normal cellular functions and survival [9]. Certain physiological and pathological factors
such as nutrient deprivation, lipids, or increased synthesis of secretory proteins can induce cell stress
and disrupt ER homeostasis by promoting unfolded protein overload [9]. Unfolded protein response
(UPR) is activated as an adaptive response to restore ER activity and maintain protein quality to
ensure proper protein synthesis, secretion, and correct folding of protein [10–12]. When ER stress is
severe and/or prolonged, it can shift toward apoptosis (cell death), although the mechanism for this
transition is not well understood [10,13–15]. ER stress has been linked to multiple disorders ranging
from neurodegenerative diseases to metabolic disorders such as obesity, insulin resistance, type 2
diabetes, and chronic inflammation [9,10,16]. Metabolically active tissue including adipose tissue is not
excluded from the ER stress outcomes [17–19]. However, the consequences of ER stress on adipocyte
functions including thermogenic capacity are poorly understood.
In adipose tissue, obesity results in chronic stress and dysfunction caused by the increased
demand of synthetic machinery [17]. Several studies have shown a significant activation of ER
stress in high-fat-induced obesity [20–22]. In addition, both brown and beige adipocyte activation
stimulated by cold exposure was impaired in obese adipose tissue [23]. Adversely, a decrease in
adaptive thermogenesis has also been suggested as a contributing factor to obesity [6]. As obesity is
characterized by diverse metabolic symptoms such as ER stress and inflammation, there is still no
direct link about how ER stress itself could regulate Ucp1 expression in beige adipocytes.
Previous study has shown that the activation of downstream signaling in ER stress, such
as that involving inositol-requiring enzyme 1α (IRE1α) and X-box binding protein 1 (XBP1),
was needed for Ucp1 expression in BAT [16]. Further, the inactivation of ER stress in BAT, WAT,
or macrophages resulted in an improved adaptive thermogenesis response [6,24], while treatment of
chemical chaperones (ER stress inhibitor) could increase energy expenditure and activate browning
of WAT [25–27]. These reports suggest a possible unknown regulatory mechanism of ER stress in
the browning of WAT. In this study, we investigated the effect of ER stress stimulation on Ucp1,
an adipocyte browning marker, in beige adipocytes.
2. Results
2.1. ER Stress Decreases Ucp1 mRNA Level in Beige Adipocytes
To investigate the regulation of ER stress on the thermogenic capacity of beige adipocytes, inguinal
white adipose tissue (IWAT) cells were differentiated to beige adipocytes and treated with tunicamycin,
an ER stress inducer. ER stress stimulation was confirmed by the upregulation of ER stress markers:
binding immunoglobulin protein (Bip) and CCAAT-enhancer-binding protein homologous protein
(Chop) (Figure 1A). Consequently, Ucp1 expression was severely suppressed (Figure 1A). The addition
of chemical chaperone 4-phenylbutyrate (PBA) alleviated ER stress markers Bip and Chop, while also
rescued Ucp1 expression (Figure 1A). These results indicate that ER stress suppressed Ucp1 expression
in beige adipocytes.
Accumulating evidence has identified the cross-talk between UPR and the mitogen-activated
protein kinase (MAPK) signaling pathway as a result of ER stress stimulation [13]. Indeed, we found
extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), which are parts
of the MAPK signaling pathway, were activated by tunicamycin treatment in our experimental
condition. Both ERK (Figure 1B) and JNK (Figure 1C) were phosphorylated after ER stress stimulation.
The addition of either ERK or JNK inhibitor (U0126 or SP600125, respectively) could ameliorate
tunicamycin-induced suppression of Ucp1 expression (Figure 1D,E and Figure S1A,B) while inhibiting
the phosphorylation of ERK (Figure 1F and Figure S1C) or JNK (Figure 1G and Figure S1D), indicating
an ER stress-induced suppression of Ucp1 expression via the activation of ERK and JNK pathway.
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Figure 1. Endoplasmic reticulum (ER) stress stimulation downregulates uncoupling protein 1 (Ucp1) 
through phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase 
(JNK) in inguinal white adipose tissue (IWAT) cells. (A) the mRNA expression levels of ER stress 
markers: binding immunoglobulin protein (Bip), CCAAT-enhancer-binding protein homologous 
protein (Chop), and adipocyte browning markers Ucp1 after treatment with 1 µM tunicamycin (Tun) 
for 12 h with or without 20 mM 4-phenylbutyrate (PBA) for 24 h before collection. Phosphorylation 
of (B) ERK and (C) JNK at different time points when treated with 1 µM tunicamycin. (D,E) Ucp1 
mRNA expression and phosphorylation of ERK (F) or JNK (G) after being treated with (D,F) 80 or 
100 µM ERK inhibitor (U0126) for 14 h, or (E,G) 25 µM JNK inhibitor (SP600125) for 13 h, followed by 
tunicamycin (1 µM; 12 h). Data are presented as mean ± S.E.M. (error bars). n = 4 in each group. 
Different letters indicate significant differences (p < 0.05) according to one-way ANOVA followed by 
Tukey–Kramer multiple comparison test. 





Figure 1. Endoplasmic reticulum (ER) stress stimulation downregulates uncoupling protein 1 (Ucp1)
through phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase
(JNK) in inguinal white adipose tissue (IWAT) cells. (A) the mRNA expression levels of ER stress
markers: binding immunoglobulin protein (Bip), CCAAT-enhancer-binding protein homologous
protein (Chop), and adipocyte browning markers Ucp1 after treatment with 1 µM tunicamycin (Tun) for
12 h with or without 20 mM 4-phenylbutyrate (PBA) for 24 h before collection. Phosphorylation of (B)
ERK and (C) JNK at different time points when treated with 1 µM tunicamycin. (D,E) Ucp1 mRNA
expression and phosphorylation of ERK (F) or JNK (G) after being treated with (D,F) 80 or 100 µM ERK
inhibitor (U0126) for 14 h, or (E,G) 25 µM JNK inhibitor (SP600125) for 13 h, followed by tunicamycin
(1 µM; 12 h). Data are presented as mean ± S.E.M. (error bars). n = 4 in each group. Different letters
indicate significant differences (p < 0.05) according to one-way ANOVA followed by Tukey–Kramer
multiple comparison test.
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2.2. ER Stress Induces Downregulation of the Ucp1 Activator, Pparγ, Preferably via the JNK Pathway
It has been previously shown that Pparγ is a direct target of both ERK and JNK, which may
result in decreased Pparγ transcriptional activity [28] and thus possibly affect Ucp1 expression.
Alongside Ucp1 downregulation, the level of Pparγ mRNA was decreased upon tunicamycin treatment
(Figure 2A,B) in IWAT cells but rescued when cells were treated with either an ERK (Figure 2A) or
JNK inhibitor (Figure 2B). Besides that, ER stress markers (Bip, Chop and X-box binding protein 1
splicing (Xbp1s)) were partially recovered through ERK and JNK inhibition (Figure 2C,D), indicating
the involvement of ERK/JNK pathway in regulating Pparγ expression.
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Figure 2. ER stress decreases Ucp1 activator, peroxisome proliferator-activated receptor γ (Pparγ)
mRNA expression through ERK and JNK pathway in IWAT cells. Pparγ and ER stress marker (Bip,
Chop, and X-box binding protein 1 splicing-Xbp1s) mRNA expression in cells treated with (A,C)
100 µM ERK inhibitor (U0126) for 14 h or (B,D) 25 µM JNK inhibitor (SP600125) for 13 h, followed
by tunicamycin (1 µM, 12 h). Data are presented as mean ± S.E.M. (error bars). n = 4 in each group.
Different letters indicate significant differences (p < 0.05) according to one-way ANOVA followed by
Tukey–Kramer multiple comparison test.
We further investigated the possibility of post-translational modifications of Pparγ through the
phosphorylation in serine 112 (S112), which is one of the main targets of ERK/JNK [29]. However,
we did not find any change in the level of phosphorylation; instead, the Pparγ protein level was
significantly reduced (Figure 3A). A time-course experiment revealed that the decrease in the Pparγ
protein level was initiated earlier than the decrease in phosphorylation of Pparγ at S112 (Figure 3B).
At this time (~4 h), ERK and JNK were both activated (Figure 1B,C). However, only treatment with
the JNK inhibitor (SP600125), but not the ERK inhibitor (U0126), could rescue Pparγ protein levels
(Figure 3C), suggesting that JNK is the main pathway for the tunicamycin-induced reduction in
Pparγ protein.
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Figure 3. ER stress decreases Pparγ protein level preferably through JNK pathway in IWAT cells. Pparγ
phosphorylation at serine 112 (S112) and Pparγ protein level in cells treated with 1 µM tunicamycin
(A) for 12 h or (B) at different time points. (C) Pparγ protein after treated with 100 µM U0126 for 14 h
or 25 µM SP600125 for 13 h, followed by tunicamycin (1 µM, 12 h). β-actin was used as a loading
control. Data are presented as mean ± S.E.M. (error bars). n = 3–4 in each group. * indicates significant
differences (p < 0.05) according to unpaired-t test. N.S., not significant.
Next, to confirm the role of Pparγ in ER stress-regulated Ucp1 expression, we treated IWAT
cells with Pparγ antagonist (GW9662). GW9662 similarly decreased Ucp1 expression as tunicamycin
(Figure 4 and Figure S2). However, the addition of GW9662 in tunicamycin treatment did not enhance
the suppression of Ucp1 expression (Figure 4 and Figure S2), suggesting that ER stress-suppressed
Ucp1 expression is indeed mediated through Pparγ.
2.3. ER Stress Stimulates Pparγ Degradation that Leads to the Reduced Binding Activity
Next, to investigate whether the decreased Pparγ protein was dependent on the decrease in
its mRNA expression, we performed a cycloheximide chase experiment to measure Pparγ protein
stability. Tunicamycin treatment seemed to accelerate Pparγ degradation under cycloheximide
addition (Figure 5A). The half-life of Pparγ was significantly reduced from 5.9 to 3.5 h upon
tunicamycin treatment (Figure 5B). However, the addition of proteasome inhibitor (lactacystin)
could rescue Pparγ protein (Figure 5C), suggesting that the degradation of Pparγ was mediated
via proteasome degradation.
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according to one-way ANOVA followed by Tukey–Kramer multiple comparison test.
To further examine the consequence of Pparγ degradation for its role as activator, luciferase
assay was done to analyze PPAR response element (PPRE) transcriptional activity under tunicamycin
stimulation. Although it was in undifferentiated IWAT cells, a luciferase assay clearly showed that
the tunicamycin treatment canceled the upregulation of PPRE transcriptional activity by rosiglitazone
(Figure 5D). However, the stabilization of Pparγ by lactacystin altered PPRE activity (Figure 5D),
indicating that Pparγ degradation indeed affects its binding activity. To finally connect the decrease
in Pparγ binding activity to Ucp1 expression, we performed chromatin immunoprecipitation (ChIP)
assay to measure the recruitment of Pparγ onto the PPRE within the Ucp1 enhancer region. As shown
in Figure 5E, the recruitment level of Pparγ to Ucp1 promoter was significantly decreased after
tunicamycin treatment. These data established that ER stress-induced Pparγ degradation was
associated with the downregulated Ucp1 expression due to the loss of Pparγ activator binding to
Ucp1 promoter.
2.4. ER Stress Suppressed Both Ucp1 mRNA and Protein Expression in Adipose Tissue
After observing a negative regulation of ER stress on Ucp1 expression in vitro, we next investigated
if the same phenomena also occur in vivo. Browning of WAT was induced by injecting Pparγ
agonist (rosiglitazone) for 10 days. As shown by the expression level of ER stress marker genes
Bip and Chop (Figure 6A), the rosiglitazone treatment had no effect on ER stress. IWAT, known as the
most typical browning-stimulated WAT, was confirmed to undergo browning through a significant
increase in Ucp1 mRNA level (Figure 6A) after rosiglitazone treatment. After beige adipocytes were
developed in IWAT, ER stress was afflicted through tunicamycin treatment. A single injection of
tunicamycin could stimulate ER stress in IWAT as indicated by elevated Bip and Chop (Figure 6A)
mRNA levels. In this state, tunicamycin canceled Ucp1 mRNA upregulation by rosiglitazone to basal
levels (Figure 6A). However, similar to in vitro result, ERK and JNK inhibition could ameliorate the
tunicamycin-suppressed Ucp1 expression ex vivo (Figure 6B). It is important to note that ERK and
JNK inhibition barely altered ER stress marker (Bip, Chop, and Xbp1s) (Figure 6B), suggesting that the
alteration of ERK and JNK pathway possibly only affect the downstream signaling of UPR, which in
this case was Ucp1 regulation.
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As mRNA expression was reduced, the Ucp1 protein level was subsequently decreased under
ER stress stimulation (Figure 6C and Figure S3A). The Ucp1 downregulation was also observed via
immunohistochemistry (IHC) of Ucp1 (Figure 6D) in IWAT. Hematoxylin and eosin (H&E) staining
showed an increasing size of lipid droplet after tunicamycin injection (Figure 6D and Figure S4),
indicating a reversal of browning (whitening). These data demonstrated that ER stress is a strong
negative regulator of Ucp1 expression in IWAT. Following the in vitro result, we also found a significant
reduction in Pparγ protein levels in vivo (Figure 7 and Figure S3B), but not mRNA levels (Figure 6A),
suggesting the decreased Pparγ protein as the main factor for Ucp1 downregulation during ER
stress stimulation.
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(A) The mRNA expression levels of ER stress markers Bip, Chop, and Xbp1s, and adipocytes browning
markers Ucp1 and Pparγ in (A) IWAT in vivo of mice injected with vehicle, 10 mg/kg rosiglitazone for
10 days (Rosi), or rosiglitazone and 10 g/kg tunicamycin (Rosi+Tun) for the last 24 h or (B) IWAT ex
vivo after reat d with 1 µM tuni cin for 24 h with or without 100 µM U01 for 26 h and 25 µM
SP600125 for 25 h. (C) Ucp1 pr level, and (D) i munohistochemical staining (IHC) of Ucp1 (scale
bar 200 µM) as well as he atoxylin and eosin (H&E) staining (scale bar 500 µM) in IWAT in vivo.
(+) indicates the positive control (brown adipose tissue). Cytochrome c oxidase subunit IV (COXIV)
were used as loading controls. Data are presented as mean ± S.E.M. (error bars). n = 3–8 in each group.
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3. Discussion
ER stress and inflammation have been known as a hallmark of metabolic syndrome. While how
inflammation could defect Ucp1 expression in adipose tissue has been reported [23,30], the effect
of ER stress in Ucp1 regulation is still unclear. However, as shown in Figure 6C, Ucp1 protein
level was not detected in the basal level of IWAT (without rosiglitazone). Subsequently, Ucp1
protein level remained undetected when ER stress was induced by tunicamycin (Figure S3A).
Therefore, we decided to investigate the effect of ER stress specifically in beige adipocytes. We first
needed to induce the formation of beige adipocytes in IWAT by using drug-induced BAT activation.
Among those, β3-adrenergic receptor agonist (such as isoproterenol) and the activators of Pparγ
(such as rosiglitazone) have been widely used for treating obesity and type 2 diabetes through the
browning-related modification in carbohydrate and lipid metabolism [31,32]. Isoproterenol and
rosiglitazone themselves have been reported to increase the levels of Ucp1 mRNA in adipocytes, thus
both drugs can be used to induce beige adipocytes [31,33–35]. However, isoproterenol is reported to
stimulate ER stress [36] while activating Ucp1, as confirmed in our preliminary experiment (data not
shown), therefore using isoproterenol did not fit this study. Unlike isoproterenol, rosiglitazone could
induce browning in beige adipocytes without afflicting ER stress, which is shown in this report. Hence,
the use of rosiglitazone would not hinder the main ER stress stimulator from tunicamycin. It is also
important to note that the long treatment of rosiglitazone has been reported to have adverse effects
such as weight gain (due to fluid retention) and the expansion of adipose tissue in many studies [37].
However, we have confirmed that our experimental model was done with no side effect in body weight
(data not shown) or adipose tissue expansion (Figure 6D).
Pparγ has been widely known as an important activator that could influence Ucp1
expression [1,38,39]. Interestingly, we found that Pparγ protein level is decreased under ER stress
stimulation even at the basal level ( s3 B). Thus, there is a possibility that ER stress-reduced Pparγ
protein would further affect Ucp1 expression and prevent WAT to undergo browning. Although this
possibility could not be proven due to low Ucp1 detection in WAT, our study clearly shows that ER
stress was indeed a strong negative regulator of both Ucp1 mRNA and protein expression in beige
adipocytes. Furthermore, ER stress stimulation seemed to increase the lipid droplet size even in the
activated beige adipocytes, which indicates whitening (reversal of browning) as shown in this study,
suggesting ER stress may closely involve to the impaired browning.
To find the mechanism under ER stress-suppressed Ucp1 expression, we first noticed the major
involvement of MAPK pathways: ERK and JNK as a part of UPR during ER stress. Among the
three ER stress sensors that have been established, IRE1 activation has been reported to promote
the phosphorylation of ERK and JNK [13,20,40], which was also shown in this study. However,
the consequences of ERK and JNK activation to Ucp1 expression during ER stress is unknown. Herein,
we found that both ERK and JNK inhibition could recover Ucp1_expression under ER stress condition,
suggesting that ER stress suppressed-Ucp1 expression might be mediated through ERK and JNK
pathways. Furthermore, Pparγ regulation by ERK and JNK during ER stress stimulation seemed to
have similar pattern as Ucp1. Following that, Pparγ protein level was also decreased by tunicamycin
treatment. However, only JNK inhibition could rescue Pparγ protein level. These results suggesting
that the reduced Ucp1 expression was mediated preferably through JNK-Pparγ interaction.
It has been known that Pparγ is a phosphorylation target of MAPK which includes ERK and
JNK [29]. Pparγ phosphorylation at Serine 112 by either ERK or JNK has been known to change Pparγ
conformation that lead to the protein degradation and repressed transcriptional activation [29,41].
However, to our surprise, we did not find significant change in phosphorylation of Pparγ. Instead,
Pparγ protein level was decreased earlier than its phosphorylation. Thus, we assume that although
JNK-mediated the reduction of Pparγ activity by phosphorylation has been established through several
studies [29,41,42], the detail mechanism may be different depending on the source of JNK activation.
In the case of ER stress, JNK might mediate the decrease of Pparγ mRNA and protein level independent
of phosphorylation modification. Accordingly, JNK activation is also known to be associated with
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apoptosis through promoting phosphorylation and activation of pro-apoptotic protein Bcl-2-associated
X protein (Bax) [13,43,44]. Indeed, we found that chronic ER stress (12–20 h) in our experimental
condition induced cell apoptosis, indicated by the upregulated Chop expression, decreased cell viability
(Figure S5A), and increased in cleavage Caspase 3 (Figure S5B,C). Chop has been reported to participate
in cell death program during ER stress [45]. On the other hand, Caspase 3 (apoptosis marker) has been
found to mediate Pparγ cleavage [46]. These pieces of evidence suggest that JNK-mediated reduced
Pparγ activity may be related to the cell apoptosis response.
Regardless, we found a consistent decrease in Pparγ activity in vitro, ex vivo, and in vivo after ER
stress stimulation. Indeed, when we reduced Pparγ activity by Pparγ antagonist (GW9662), it similarly
downregulated Ucp1 expression as tunicamycin. Furthermore, the co-treatment between tunicamycin
and GW9662 did not enhance the suppression of Ucp1 expression, suggesting that both compounds
regulated Ucp1 expression preferably through the same pathway, which in this case was through
Pparγ. To finally connect the consequence of Pparγ reduction to Ucp1 expression, we investigated
the PPRE activity under tunicamycin treatment. Ucp1 is one of the established activation target of
Pparγ in adipose tissue, equipped with PPRE binding sequence located on the Ucp1 distal enhancer
(-2494 to -2318 bp) [1]. Herein, we showed that PPRE activity was significantly affected after ER
stress stimulation, based on the luciferase assay. Although it was performed in undifferentiated
IWAT cells due to the low transfection efficiency in differentiated cells, we further confirmed in ChIP
assay that Pparγ recruitment to Ucp1 promoter was consistently reduced in differentiated IWAT cells.
These pieces of evidence thus show that the reduced Pparγ binding to Ucp1 promoter are likely due
to the decreased protein level and subsequently affected Ucp1 mRNA downregulation as ER stress
was stimulated.
While the reduced Pparγ mRNA expression was only seen in vitro, the Pparγ protein level
was decreased both in vitro and in vivo. These results might indicate that the loss of Pparγ protein
was not dependent on its mRNA expression. Later, we found that Pparγ protein stability was
disturbed by ER stress stimulation, suggesting that Pparγ protein was degraded. In addition,
it has been known that ER stress induction could lead to the activation of protein degradation
pathway to remove the accumulation of unfolded protein [14]. Basically, there are two major
protein degradation pathways: proteasomes (via ER-associated degradation or ERAD) and lysosome
(via autophagy) degradation [14,47]. Between two pathways, ERAD is recognized as the predominant
cellular mechanism for removal of unfolded protein [14,48]. Certainly, the addition of proteasome
inhibitor (lactacystin) rescued Pparγ protein and PPRE activity, suggesting proteasome-mediated
Pparγ degradation affects its binding activity to Ucp1 promoter during ER stress stimulation in
beige adipocytes.
Interestingly, the induction of ER stress did not only affect Ucp1 mRNA expression, but also
Ucp1 protein level. Although, it might be linear to the decreased in mRNA expression, there still
has possibility that the reduced Ucp1 protein level was affected directly through ERAD mechanism.
Therefore, further investigation is needed to carefully assess Ucp1 protein modification in ER stress.
Regardless, this study presents a novel evidence about the negative regulation of ER stress signaling to
Ucp1 expression via the suppression of activator Pparγ in beige adipocytes.
4. Materials and Methods
4.1. Materials
All chemicals were obtained from Nacalai Tesque (Kyoto, Japan), Wako (Osaka, Japan), Corning
(Corning, NY, USA), Qiagen (Hilden, Germany), Invitrogen (Carlsbad, CA, USA), and Sigma-Aldrich
(St. Louis, MO, USA). Tunicamycin, U0126, SP600125, and cycloheximide were purchased from Nacalai
Tesque (Kyoto, Japan). GW9662 (Sigma-Aldrich, St. Louis, MO, USA), rosiglitazone (LKT Laboratories,
St. Paul, MN, USA), and PBA (Santa Cruz Biotechnology, Dallas, TX, USA) were acquired from the
indicated companies.
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4.2. Animal Experiment
Mice were kept in a temperature-controlled room at 23 ± 1 ◦C with a 12 h light/dark cycle and
free access to food (standard diet) and water. To stimulate browning, 6–10-week-old male C57BL/6J
mice (SLC, Shizuoka, Japan) were intraperitoneally injected with 10 mg/kg rosiglitazone daily for
10 days [49]. On Day 10, 10 mg/kg tunicamycin was injected to induce ER stress. Mice were then fasted
overnight. Twenty-four hours after the last injection, mice were sacrificed, and IWAT was harvested
for mRNA and protein analysis. The mice were handled in accordance with procedures approved by
the Kyoto University Animal Care Committee (Permission number: 29-62, 20 April 2012).
4.3. Ex Vivo Experiment
To stimulate browning, 6-week-old male C57BL/6J mice (SLC, Shizuoka, Japan) were
intraperitoneally injected with 10 mg/kg rosiglitazone daily for 10 days [49]. Twenty-four hours
after last injection, IWAT was collected and immediately incubated in serum free medium containing
1 µM tunicamycin for 24 h with or without 100 µM ERK inhibitor (U0126) for 26 h/25 µM JNK inhibitor
(SP600125) for 25 h. IWAT was then extracted for mRNA analysis.
4.4. Cell Culture
Immortalized primary IWAT cells were kindly provided by Dr. S. Kajimura (University of California,
San Francisco, CA, USA). IWAT cells were maintained in a humidified 5% CO2 atmosphere at 37 ◦C using
basic medium (DMEM) supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin.
To induce the differentiation into beige adipocytes [49], two days post-confluent IWAT cells were
stimulated with 0.5 mM 1-methyl-3-isobutylxanthine, 2 µg/mL dexamethasone, 10 µg/mL insulin,
1 nM triiodo-L-thyronine (T3), 0.5 µM rosiglitazone (rosi), and 125 µM indomethacin for 48 h. The
media was then replaced by basic medium containing 5 µg/mL insulin, 1 nM T3, and 0.5 µM rosi every
2 days. Generally, the differentiation process took 8–10 days. ER stress was induced by the addition of
tunicamycin (1 µM) in serum-free medium for 12 h, unless mentioned.
4.5. RNA Preparation and Quantification of Gene Expression
RNA was extracted as described previously [50]. Total RNA was collected from cultured cells or
tissues using Sepasol-RNA I Super G (Nacalai Tesque, Kyoto, Japan) or QIAzol Lysis Reagent (Qiagen,
Hilden, Germany), respectively. RNA expression was quantified by real-time PCR using a LightCycler
System (Roche Diagnostics, Mannheim, Germany) with SYBR green fluorescence signal detection. All
mRNA signals were normalized to a 36b4 internal control. The primer sequences are listed in Table 1.







4.6. Protein Extraction and Western Blotting
Western blotting was performed as previously described [50]. The protein concentration was
measured using the DC protein assay (Bio-Rad, Hercules, CA, USA). The primary antibodies included
anti-Ucp1 (Sigma-Aldrich, St. Louis, MO, USA), anti-COXIV, anti-phospho-p44/42 MAPK (ERK1/2),
anti-phospho-SAPK/JNK (Thr183/Tyr185), anti-SAPK/JNK, anti-Pparγ, and anti-β-actin (all purchased
from Cell Signaling Technology, Danvers, MA, USA). The secondary antibody staining was visualized
using a chemiluminescent horseradish peroxidase substrate (Millipore, Burlington, MA USA).
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4.7. Chromatin Immunoprecipitation (ChIP) Assay
The ChIP assay was performed as described previously [50]. The cells were subjected to overnight
immunoprecipitation with 8 µg Pparγ antibody (Perseus Proteomics, Tokyo, Japan), or rabbit IgG
isotype control (Novus Biological, Littleton, CO, USA) as a mock control and analyzed by real-time
PCR. The primer sequences are listed in Table 2.
Table 2. Primers used in ChIP assay.
Gene Forward Reverse
Ucp1 enhancer 5′-CTCCTCTACAGCGTCACAGAGG-3′ 5-AGTCTGAGGAAAGGGTTGA-3′
4.8. Luciferase Assay
The luciferase assay was performed according to company protocol (Invitrogen, Carlsbad, CA,
USA). Undifferentiated IWAT cells were transfected with plasmid containing the reporter vector driven
by PPAR response element (PPRE-Luc) and a Pparγ expression vector using Lipofectamine 2000
reagent (Invitrogen, Carlsbad, CA, USA). The transfected cells were treated with 0.5 µM rosiglitazone
for 24 h and 10 µM tunicamycin with or without 10 µM lactacystin for 4 h.
4.9. Statistical Analysis
All data were analyzed using Student’s t-test or one-way ANOVA followed by Tukey–Kramer
test, when variances were heterogeneous. All data are presented as means ± SEM. Differences were
considered significant at p < 0.05.
5. Conclusions
The present study highlights a novel mechanism of ER stress regulation to Ucp1 expression
preferentially via the suppression of activator Pparγ in beige adipocytes. Furthermore, it may provide
a solid foundation about the involvement of ER stress to the impaired thermogenic capacity, especially
in obese adipose tissue. Thus, recovering ER stress is proven essential to rescue thermogenic activity
in adipose tissue.
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β-AR beta-adrenergic receptor
BAT brown adipose tissue
Bip binding immunoglobulin protein
ChIP chromatin immunoprecipitation
Chop CCAAT-enhancer-binding protein homologous protein
COXIV cytochrome c oxidase subunit IV
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ER endoplasmic reticulum
ERAD ER-associated degradation
ERK extracellular signal-regulated kinase
H&E hematoxylin and eosin
IHC immunohistochemical staining
IRE1α inositol-requiring enzyme 1 alpha
IWAT inguinal white adipose tissue
JNK c-Jun N-terminal kinase
MAPK mitogen-activated protein kinase
PBA 4-phenylbutyrate
Pparγ peroxisome proliferator-activated receptor gamma




Ucp1 uncoupling protein 1
WAT white adipose tissue
XBP1s X-box binding protein 1 splicing
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